THE DR. MARTENS LOAFER COLLECTION: FROM SEASONAL STAPLE TO YEAR-ROUND ESSENTIAL

NEW YORK, Sept. 8, 2026 /PRNewswire/ -- No fall wardrobe is complete without a pair of loafers, and no one does them better than Dr. Martens. Rooted in unmistakable DM's DNA, each style reimagines the classic loafer silhouette with a contemporary take, creating must have, versatile shoes, taking wearers through autumn and the seasons beyond.

'The loafer has become one of the most versatile shoes in the modern wardrobe. The penny loafer traces its roots back to early 20th-century Europe but became a fashion statement among students in 1950s America, emerging alongside the rise of youth culture. Today, the silhouette is worn year-round, with creatives, designers and the zeitgeist embracing loafers as a smart alternative to sneakers and a reliable investment piece that moves effortlessly between seasons.'

– John Hensman, Head of Design – Footwear: Dr. Martens

The Mayfare Loafer is the ultimate penny loafer — complete in Polished Black Smooth leather, it's a staple for elevated dressing this fall. Inspired by heritage design, it's moc toe shape and penny strap pay homage to classic design, perfect for elevating a casual look. Built on a V18 low-profile sole with subtle welt, it offers a sleeker take on some of DM's more classic styles.

A fan favorite, the Adrian Tassel Loafer offers a formal take on the tassel loafer. Crafted from rich Burgundy Arcadia leather, these shoes bring a bold edge to day to night dressing. Built on DM's signature air-cushioned sole and finished with Goodyear-welted heat-sealed construction, they combine all day comfort with Dr. Martens durability.

Versatility is key when dressing for transitional weather, and the Penton Loafer in Spiced Brown does just that. Featuring include a moc toe, penny slot and deep cleats; balancing iconic detailing, for a more relaxed take. Crafted from Mayhem leather, the corrected grain delivers a smooth finish while maintaining depth and character, designed for wearers who never compromise on style. The loafer is complete on a BEN sole with air-cushioned comfort and signature yellow welt stitching, great for wearers on the go.

Finally, the Delapre Penny Loafer, crafted from Repello Calf suede, offers an elevated take on the timeless leather loafer. Part of the Made in England range, the material is a fine grade suede from the legendary C.F. Stead tannery. Each pair is treated with a Scotchgard finish for enhanced protection against water and stains, making them the perfect companion for fall dressing. Signature penny slot and moc toe detailing are paired with iconic Dr. Martens touches, including the heat-sealed, groove-edge construction and signature air-cushioned sole.

The Dr. Martens loafer collection is available to shop now via drmartens.com, and in Dr. Martens stores and through selected retailers worldwide.

ADRIAN ARCADIA LEATHER TASSEL LOAFERS

CHERRY RED — ARCADIA LEATHER

MAYFARE SMOOTH LEATHER LOAFERS

BLACK — POLISHED SMOOTH LEATHER

PENTON LOAFER MAYHEM LEATHER 

SPICED BROWN — MAYHEM LEATHER

DELAPRE PENNY REPELLO CALF SUEDE LOAFERS

BROWN — REPELLO CALF SUEDE MB

ABOUT DR. MARTENS

Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot - named after the date it was produced - rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, "Docs" or "DM's" were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.

Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people. The company continues to honour the brand's heritage through its 'Made in England' footwear, manufactured at its original Northamptonshire factory, while meeting global demand from multiple high-quality production sites across Asia. All our products are made with an unwavering commitment to craft, combined with innovative techniques.

A brand built to put a bounce in the step of those who stand out from the crowd, Dr. Martens is available through Direct-to-Consumer (Retail and Ecommerce) and Wholesale channels. The brand's collections range from its Original silhouettes - The Icons such as the 1460 boot, 1461 shoe, 2976 Chelsea boot, and Adrian loafer - to modern franchises like the Zebzag, Buzz, and Lowell. The lineup also includes an extensive range of sandals, a dedicated Kids collection, and a curated selection of bags, small leather goods, and accessories.

Every Dr. Martens product reflects craftsmanship, heritage, timeless style, comfort, and versatility. Having transcended generations, the brand stays as relevant today as it was at its inception. Its signature yellow welt stitching, grooved sole edges, and scripted "With Bouncing Soles" heel loops remain iconic symbols recognised around the world.

Dr. Martens plc (DOCS.L) is listed on the main market of the London Stock Exchange and is a constituent of the FTSE 250 index.

For more information, visit www.drmartens.com or www.drmartensplc.com

SOURCE Dr. Martens

Share this article

New marquee client wins, a new seven-practice model, and its own AI-search tool, BASE,

pushed the agency more than 1,700 spots up the Inc. 5000 in four years.

SCOTTSDALE, Ariz., Sept. 8, 2026 /PRNewswire/ -- Brilliant, an award-winning, modern performance agency bridging integrated PR, influencer strategy, and next-generation digital discovery is experiencing unprecedented growth. Over the last 12 months, the agency expanded its roster with marquee consumer accounts, reorganized into seven strategic practice areas, and unveiled BASE, a proprietary platform that ensures brands appear in AI-driven answers. Driving this momentum is a jump to No. 1,847 on the 2026 Inc. 5000 list, up from No. 3,562 in 2022.

Key Facts

- New business: The agency has added an impressive and diverse lineup to its existing client roster with recent new business wins including Haakaa, Baby Brezza, Veer, b.bot, Sera Prognostics, Mira, Napa Cellars, and several others.

- New operating model: Built for today's digital ecosystem, Brilliant's seven strategic practice areas comprise four client-facing divisions powered by three core operational engines. By uniting earned moments, paid reach, and AI intelligence into synchronized beats, the agency is built to move at the speed of culture.

- Proprietary AI-visibility platform: BASE (Brilliant Analytics & Strategy Engine) designs campaigns to appear in AI search results across ChatGPT, Google AI, Perplexity, and Claude, and provides critical citations to inform earned media actions.

- Proof of growth: No. 1,847 on the 2026 Inc. 5000, up more than 1,700 spots from No. 3,562 in 2022, on 188% three-year revenue growth.

- Where to learn more: www.brilliant-agency.com

Built for how today's consumer discovers brands

The way people search is changing daily. Instead of clicking through pages of Google results, consumers are asking ChatGPT, Gemini, Claude, and Perplexity directly for recommendations, product suggestions, and answers. AI-generated responses now appear before traditional search results, meaning brands that are not showing up in those answers are increasingly being left out of the conversation.

- BASE, Brilliant's Analytics & Strategy Engine, was built to help brands understand and improve how they appear across AI platforms. It tracks AI visibility, analyzes how AI tools describe and position a brand, identifies gaps or misinformation, and benchmarks performance against competitors across major LLMs.

- BASE helps make media outreach smarter and more strategic by identifying the outlets, narratives, and sources AI models trust most. It can uncover content gaps, flag reputation risks, recommend high-impact earned opportunities, and help prioritize the messaging most likely to improve AI visibility and brand authority.

- Brilliant uses BASE to make campaigns, content, and media outreach more effective for clients by identifying the stories, outlets, expert angles, and messaging most likely to drive both traditional earned coverage and AI visibility. It helps ensure the work is not just generating headlines today, but also improving how brands are surfaced and recommended across the rapidly growing AI search ecosystem.

One team, seven practice areas

In 2026, Brilliant rebuilt how the agency operates, sorting every capability into seven practice areas: four that face clients, three that power every account.

- PR & Experiential turns brands into moments people talk about and coverage they care about.

- Social & Content makes brands impossible to scroll past.

- Influencer & Celebrity authentically places the right creators and famous faces behind every idea.

- Paid & Advertising adds reach and scale when the brief calls for it.

- Insights & Intelligence tracks what's working and suggests performance optimization, including AI and search.

- Operations & Culture keeps the work running and the team thriving.

- Growth & Development focuses on the future.

Proof in the numbers

The Inc. 5000 ranks U.S. private companies by three-year revenue growth. Brilliant ranked No. 1,847 in 2026, up from No. 3,562 in 2022, a jump of more than 1,700 spots in four years, on 188% three-year revenue growth. That's well above the 130% median for the 2026 list. That jump lines up with the new clients and the agency's new way of working.

A word from the agency

"The way people find brands is changing fast, and we rebuilt Brilliant to lead it," said Kathleen Tomes, Founder and CEO, Brilliant. "New clients, a new practice model, and our own AI-search engine are the real story. The Inc. 5000 jump is proof it's working. None of it happens without clients who trust us and a team that adapts fast."

Frequently Asked Questions

What is Brilliant? Brilliant is an award-winning, modern performance agency bridging integrated PR, influencer strategy, and next-generation digital discovery backed by its own proprietary AI-visibility platform, BASE.

What is BASE? BASE (Brilliant Analytics & Strategy Engine) is Brilliant's proprietary AI-visibility platform. It helps design campaigns so brands appear in the answers people get from AI models like ChatGPT, Google AI, Perplexity, and Claude.

What is driving Brilliant's growth? Growth is being driven by investment in AI & Technology, the addition of a new SVP of Operations and Client Success, the streamlining of a seven-practice operating model, and a big bet on LLM search.

How fast is Brilliant growing? Brilliant posted 188% three-year revenue growth (2022–2025), well above the 130% median for the 2026 Inc. 5000. It ranked No. 1,847 on the list, up from No. 3,562 in 2022, a gain of more than 1,700 spots in four years.

Where can I learn more about Brilliant? Visit www.brilliant-agency.com.

Is Brilliant hiring? Yes. The remote team is growing, and open roles are posted at www.brilliant-agency.com.

Brilliant is an award-winning, modern performance agency bridging integrated PR, influencer strategy, and next-generation digital discovery. Leveraging proprietary tools alongside full-funnel marketing campaigns, Brilliant helps emerging and category-leading brands capture attention, navigate evolving media landscapes, and generate proven ROI. See the work at www.brilliant-agency.com or follow along on Instagram, TikTok, and Facebook.

Media Contact:

Christianna Pally

[email protected] 

SOURCE BRILLIANT PR & MARKETING

Share this article

The new practice combines expert-led agentic services with Cye's AI-native platform to help PE firms manage portfolio companies' cybersecurity programs and their exposure from due diligence through the holding period to sale.

HERZLIYA, Israel, Sept. 8, 2026 /PRNewswire/ -- Cye, a leader in cyber exposure management, today announced the launch of its Center of Excellence for Private Equity (PE), with a new operating model designed to help private equity firms assess, manage and reduce cyber exposure across their portfolios throughout the investment lifecycle.

Private equity firms and their portfolio companies are increasingly high-value operational targets for attackers. They concentrate capital, sensitive deal data and interconnected third-party providers, creating opportunities to disrupt transactions, steal sensitive information and exploit shared services by portfolio companies to achieve blast-radius impact.

Yet cybersecurity is often managed through point-in-time assessments at individual portfolio companies, leaving PE firms without a consistent, portfolio-wide view of their security posture, their organizational exposure or cyber resilience improvement throughout their holdings.

"Cybersecurity is becoming a powerful lever for creating enterprise value - not just a cost center to manage," said Reuven Aronashvili, CEO of Cye. "When firms can understand cyber exposure consistently across their portfolios and actively reduce it, they turn cybersecurity into a measurable driver of long term value to protect investments and increase acquisition multiples".

The Center of Excellence acts as the central operating hub for portfolio cybersecurity, standardizing execution across investments and applying cross-portfolio insights and actions to strengthen decision-making, operational support and continuous exposure reduction.

Cye combines its expert-trained AI-native exposure management platform and M&A related services to deliver continuous, portfolio-wide oversight with a unified system of record and reporting:

- Pre-Deal Scouting:

Provides an early view of a target's cyber exposure before formal due diligence, surfacing red flags that could affect valuation, deal terms, or the decision to proceed.

- 360-degree Due Diligence:

Provides a comprehensive view of a target's cyber exposure before acquisition, identifying acquisition blockers, negotiation levers, and risks that could affect the transaction.

- 90-Day Cyber Onboarding and Uplift Program:

Establishes a clear post-acquisition cybersecurity baseline posture, prioritizes actions needed to address critical gaps, giving newly acquired companies a focused path to improving their security posture.

- Continuous Exposure Management:

Continuously identifies, prioritizes, and reduces cyber exposure across portfolio companies, combining validated exploitability with business impact and mitigation planning to focus resources toward the actions that can most effectively reduce portfolio risk.

- PE-Level Management:

Gives PE firms a centralized view of cyber exposure and maturity across their portfolio, enabling them to compare companies, identify those with elevated or deteriorating risk, prioritize investment, and track progress at the group level.

- Exit Readiness:

Demonstrates measurable improvement in cyber maturity and exposure ahead of exit, providing evidence of exposure reduction and helping strengthen the firm's position in the transaction.

Cye's CoE for Private Equity is available to private equity firms globally.

Learn more about Cye's Private Equity offering

About Cye

Cye is an AI‑native exposure management platform that reveals real‑world exploitable attack paths and quantifies business impact in financial context. Cye enables organizations to prioritize and act accurately - remediate, mitigate, or accept risk - with clarity and confidence amidst the dynamic threat landscape. Learn more at cyesec.com

Media Contact

Lee-El Aviad

[email protected]

SOURCE Cye

Share this article

With over two decades of health tech marketing and communications leadership, Konstantinidis joins to amplify AssureCare's market momentum, accelerate adoption and extend its presence into new segments.

CINCINNATI, Sept. 8, 2026 /PRNewswire/ -- AssureCare®, a leading AI-powered population health management company, today announced that Kristen Konstantinidis has joined the company as Senior Vice President of Marketing and Communications.

Healthcare organizations are under more pressure than ever to adopt AI-enabled technology that actually delivers results, not just promises them. For too long, healthcare technology has promised interoperability, actionable intelligence, and whole-person care – but too often has delivered fragmented point solutions, disconnected data, and innovation that fails to translate into meaningful action at the point of care. AssureCare has spent years building something different: a platform that connects stakeholders, turns complex data into usable insights, and enables care teams to intervene with clarity, speed, and purpose. Now the company is building the team to make sure the market knows it.

"Kristen has a rare gift for translating complex technology and true healthcare outcomes into ROI-driven success stories that resonate, regardless of the audience – whether that's a boardroom, policy table, or clinical floor," said Yousuf Ahmad, President and CEO of AssureCare. "AssureCare is not simply building technology. We are redefining how healthcare organizations identify needs earlier, coordinate care more effectively, and improve outcomes for the people and communities they serve. There's no one better suited to share that story with stakeholders than Kristen."

Most recently, Konstantinidis served as Chief Communications Officer at Homeward Health, where she built the company's communications and brand marketing function – including government relations, positioning for the Rural Health Transformation (RHT) Program, and AI narrative strategy. That experience gives her particular insight into one of the most consequential shifts in healthcare today: the move toward responsible, AI-enabled, proactive care. She brings it to AssureCare to help tell the story of how intelligent technology and compassionate care work together to remove friction instead of adding it, so the people delivering care can stay focused on the people who need it.

"I chose AssureCare because of the combination of an exceptional team, compelling mission, proven technology, and enormous opportunity," said Konstantinidis. "At AssureCare, AI is not a slogan or a disconnected feature, it is an enabler of better decisions, more efficient care teams, stronger engagement, and measurable outcomes. My job is to make sure the market knows the scale, effectiveness and impact AssureCare makes on millions of lives, and I can't think of more meaningful work to be part of."

About AssureCare®

AssureCare is a leading provider of AI-powered population health management solutions designed to manage large, complex populations. AssureCare enables healthcare organizations to digitize care processes, optimize clinical and financial performance, and personalize member engagement across the continuum. Serving some of the nation's largest health plans, government agencies, providers, pharmacies, and community organizations, AssureCare's platform supports more than 60 million lives through intelligent care management, analytics, and engagement solutions. The company continues to lead the industry in applying responsible AI and advanced technology to improve healthcare outcomes and operational efficiency. AssureCare is a proud member of the Vora Ventures portfolio.

Learn more: www.assurecare.com

Media Contact

Emily Frizzi

[email protected]

SOURCE AssureCare

Share this article

The Property Lab is part of Allstate's broader investment in claim adjusters, equipping them with practical knowledge that helps them guide customers through the repair and recovery process.

Mike Fiato, executive vice president and chief claims officer at Allstate:

"Customers trust Allstate during some of the most stressful moments they face as homeowners. The Property Lab gives our teams hands-on experience with real-world damage scenarios, helping them provide informed guidance and support when it matters most."

Frequently Asked Questions

What is the Property Lab at Allstate Claims University?

The Property Lab is a hands-on training environment that allows claim adjusters to experience realistic residential damage scenarios in full-scale homes. Claim adjusters can inspect damage, examine what may be happening behind walls, ceilings and floors and gain firsthand experience with the situations they may encounter while helping customers recover. The homes feature a range of construction materials and finishes, from standard-grade components to higher-end materials, helping claim adjusters gain experience with the variety of homes, materials and repair considerations before directly supporting customers.

How does Allstate train property claim adjusters?

The Property Lab prepares claim adjusters for real-world home damage scenarios by:

- Inspecting visible damage on the exterior and interior of full-size, two-story homes.

- Using cutaway wall sections to trace how damage travels through framing, insulation and plumbing.

- Engaging with interactive digital tools showing damage patterns and repair techniques.

- Practicing identifying hidden damage beyond the visible point of origin.

- Completing module-based training on roofing, water damage, cabinetry, plumbing, electrical and sump-pump systems.

What kinds of damage are featured in the Property Lab?

The Property Lab recreates a variety of situations commonly encountered in residential property claims, including:

- Water and plumbing damage, including burst pipes, water intrusion, leaking appliances and drain backups

- Roof, hail and storm-related exterior damage, including roof and skylight leaks 

- Fire, smoke and heat-related damage, including smoke and grease-fire damage and fire-related siding damage

- Lightning-related damage to home systems and equipment, including HVAC units and electrical components

What equipment and technology does the Property Lab use to train claim adjusters?

The Property Lab combines physical damage demonstrations with digital learning tools that provide immediate information about damage patterns, repair techniques and restoration considerations. Interactive technology throughout the homes allows claim adjusters to move beyond observation and explore how different types of damage develop, spread and are repaired.

The facility also includes industry-standard roofing, water damage, cabinetry, plumbing, electrical and sump-pump training modules, creating a learning experience that closely mirrors conditions encountered in residential claims.

What happens during an Allstate home insurance claim inspection?

When a homeowner files a property claim with Allstate, a claim adjuster assesses both visible and potential hidden damage, evaluates how the damage originated and spread through the home's structure, reviews applicable coverage and guides the homeowner through repair options and next steps. The Property Lab prepares claim adjusters for this process, particularly for cases where the visible damage is only part of the story.

About Allstate 

The Allstate Corporation (NYSE: ALL) protects people from life's uncertainties with affordable, simple and connected protection for autos, homes, electronic devices and identities. Products are available through a broad distribution network including Allstate agents, independent agents, major retailers, online and at the workplace. Allstate has 216 million policies in force and is widely known for the slogan "You're in Good Hands with Allstate." For more information, visit www.allstate.com.

SOURCE Allstate Insurance Company

Share this article

New edition highlights emerging disclosure trends, investor priorities and best practices for creating more effective proxy communications

NEW YORK, Sept. 8, 2026 /PRNewswire/ -- Donnelley Financial Solutions (NYSE: DFIN), a leading global provider of financial regulatory and compliance solutions and the top SEC filing agent, today announced the release of its 14th Annual Guide to Effective Proxies, an in-depth resource designed to help public companies strengthen shareholder communications while meeting evolving regulatory and governance expectations.

Drawing insights from over 1,500 proxy statements and showcasing examples from over 300 leading public companies that DFIN supports in the creation of their proxies, the 2026 guide provides practical insights on enhancing proxy disclosures, improving design and readability, and effectively communicating governance, compensation and long-term value creation strategies to investors. The guide builds on DFIN's annual analysis of proxy statement trends and emerging best practices across the public company landscape.

"Amid the swirl of informal communications and proliferating information channels, the proxy is a reliable source for clear, comparable and strategic company data," said Leah Trzcinski, Chief Legal and Compliance Officer at DFIN. "The Guide to Effective Proxies helps organizations move beyond compliance and create disclosure documents that foster trust, support shareholder engagement and tell a compelling corporate story."

Key Topics Featured in the 14th Edition

The latest edition explores several areas shaping the future of proxy communication, including:

- Artificial Intelligence and Emerging Risks – Examples of how organizations are addressing AI governance, technology oversight and related disclosure considerations.

- Board Oversight and Governance Transparency – Strategies for clearly communicating board composition, leadership structure and risk oversight responsibilities.

- Executive Compensation Disclosure – Approaches for simplifying compensation discussions and strengthening pay-for-performance narratives.

- Cybersecurity and Enterprise Risk Management – Evolving practices for communicating cyber preparedness and board oversight of the highest priority risks.

- Human Capital and Workforce Strategy – Techniques for highlighting talent initiatives, employee development and organizational culture.

- Proxy Design and Shareholder Engagement – Best practices for improving readability, accessibility and overall shareholder experience.

"Proxy statements have become one of the most important opportunities companies have to communicate directly with investors," said Ron Schneider, Director of Corporate Governance Services at DFIN. "This year's guide highlights innovative ways organizations are increasing transparency, improving engagement, linking complex governance disclosures to the company's business strategy, making them easier to understand and support."

Supporting Better Proxy Creation Through DFIN ActiveDisclosure

Many of the proxy statements featured in the guide were developed using ActiveDisclosureSM, DFIN's financial reporting and disclosure management solution. Designed to streamline collaboration across legal, finance, investor relations and governance teams, ActiveDisclosure helps organizations improve accuracy, manage version control and create professional, investor-focused disclosure documents more efficiently. The platform also provides powerful document design capabilities, including multi-column layouts, advanced typography controls and rich data visualizations, enabling companies to create more engaging and visually compelling proxy statements.

Turn proxy season into a strategic advantage. Join us on September 14, 2026, at 1 p.m. ET for a live discussion on the latest insights from the 14th Annual Guide to Effective Proxies. Register now.

About DFIN

DFIN is the leading global provider of compliance and regulatory software and services, fueling end-to-end investment company regulatory compliance needs, complex capital markets transactions, and essential financial reporting at every stage of the corporate lifecycle. Our mission is simple: to empower clients with the software and service they need to stay ahead of public company filings, investment company filings, private reporting, and beneficial owner reporting, while enhancing workflow efficiency. We bring deep expertise to every engagement, driving transparency and collaboration built on confidence and reliability. Learn more at DFINsolutions.com or follow us on LinkedIn.

SOURCE Donnelley Financial LLC

Share this article

Television Host and Entertainment Journalist Josh McBride signs with WME and secures exclusive Acast partnership as The McBride Rewind podcast accelerates national growth

NEW YORK, Sept. 8, 2026 /PRNewswire/ -- The McBride Rewind, the celebrity interview podcast hosted by television personality Josh McBride, has signed with WME for representation in all areas and entered into an exclusive partnership with Acast, expanding the show's reach as it continues to gain momentum in the entertainment podcast space.

Since its debut earlier this year, The McBride Rewind has become known for candid conversations with actors, musicians and television personalities whose work helped define late-'90s and early-2000s pop culture. Recent guests include Whoopi Goldberg, Ja Rule, Jodie Sweetin, Christine Taylor, Andrew Keegan, Mýa and Nina Sky. Several episodes have generated follow-on coverage in outlets including People and Page Six, with conversations extending beyond nostalgia into topics such as residuals, career reinvention, and the changing realities of working in Hollywood.

Acast will provide global distribution, advertising sales, and monetization support, while WME will represent the podcast as it expands across digital media, branded content, live opportunities and additional entertainment ventures. "I've always believed the best interviews happen when people forget they're being interviewed," said McBride. "Those are the moments listeners connect with most. Every guest has a story that goes beyond the role or the hit song people remember, and that's what we've built the show around. Having Acast and WME behind us allows us to keep growing while staying true to that approach."

"Josh has created a format that feels both familiar and fresh," said Jaclyn Wertheimer, Senior Development Manager at Acast. "His guests are comfortable opening up, and those conversations often become part of larger entertainment news cycles. We're looking forward to bringing the show to an even wider audience and introducing new advertising partners to such an engaged fan base."

Rather than simply revisiting memorable moments from pop culture, The McBride Rewind focuses on the careers behind them. Guests reflect on the successes, challenges and turning points that shaped their lives, offering listeners a perspective that's both nostalgic and relevant to today's entertainment landscape.

With support from WME and Acast, the podcast will continue to expand its guest lineup while exploring new opportunities across audio, video and live programming.

The McBride Rewind is available on Apple Podcasts, Spotify, YouTube and wherever podcasts are distributed.

About Josh McBride

Josh McBride is a television host, producer and entertainment journalist with nearly 15 years of on-air experience. He has appeared on programs including Today, Good Morning America, The Wendy Williams Show, The Talk and numerous national and syndicated broadcasts. He is recognized for his conversational interview style and longstanding relationships throughout the entertainment industry.

About The McBride Rewind

The McBride Rewind is a weekly interview podcast featuring conversations with actors, musicians and entertainers whose work helped shape late-'90s and early-2000s pop culture. Each episode looks beyond the headlines, exploring the careers, creative journeys and personal stories behind some of entertainment's most recognizable names.

About Acast

Acast is the global authority on podcasting, building the infrastructure that serves as the single point of entry for the whole industry. This enables creators to grow and monetize across audio, video, social, and beyond, and brands to buy at scale - without walls or borders. As the world's largest pure-play podcast company, we connect 140,000+ storytellers with 4,000+ advertisers globally. Listed on Nasdaq Stockholm (ACAST).

SOURCE The McBride Rewind

Share this article

Acquisition establishes Labcorp as the only central laboratory provider with a wholly owned laboratory network across four continents

BURLINGTON, N.C., Sept. 8, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the acquisition of MLM Medical Labs (MLM), a leading global central and specialty laboratory provider with operations across the United States, Germany and South Africa. Financial terms of the transaction were not disclosed.

The acquisition enhances Labcorp's position as a leading independent central laboratory services provider by expanding its presence in key clinical research regions and strengthening its biomarker and specialty testing capabilities. The transaction expands Labcorp's laboratory footprint and establishes Labcorp as the only central laboratory provider with a wholly owned laboratory network across four continents: North America, Europe, Asia and Africa. The combination brings together Labcorp's global scale, breadth of scientific capabilities and operational infrastructure with MLM's established laboratory network and science-led service model.

"Clinical trial sponsors today need scientific expertise, global reach and operational flexibility to advance increasingly complex development programs," said Brian Caveney, M.D., EVP and president, biopharma laboratory services and chief medical and scientific officer, Labcorp. "MLM complements Labcorp's existing strengths and enhances our ability to support sponsors of all sizes, from emerging biotechs to leading pharmaceutical companies. Together, we are well positioned to provide the capabilities, regional expertise and high-touch support sponsors need to advance innovative therapies worldwide."

This integrated global infrastructure enhances Labcorp's ability to support complex multinational clinical trials with consistent scientific, operational and regulatory oversight from a single trusted partner. The acquisition also expands Labcorp's laboratory footprint in critical clinical research markets, including Africa, where MLM operates the continent's first fully CAP-accredited central laboratory.

In addition, the acquisition strengthens Labcorp's scientific and regulatory expertise and broadens access to biomarker and specialty testing capabilities that support increasingly complex clinical development programs.

This acquisition reflects Labcorp's ongoing commitment to investing in central laboratory services and meeting the evolving needs of clinical trial sponsors worldwide.

Evercore served as exclusive financial advisor to Labcorp and Pierson Ferdinand and Hogan Lovells served as Labcorp's legal counsel.

About Labcorp 

Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com. 

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements with respect to the acquisition of MLM Medical Labs and how its capabilities are anticipated to benefit clinical trial sponsors.

Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the company's control. These factors, in some cases, have affected and in the future (together with other factors) could affect the company's ability to implement the company's business strategy, and actual results could differ materially from those suggested by these forward-looking statements. As a result, readers are cautioned not to place undue reliance on any of the forward-looking statements.

The company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the company's most recent Annual Report on Form 10-K under the heading RISK FACTORS and in the company's other filings with the SEC. The information in this press release should be read in conjunction with a review of the company's filings with the SEC including the information in the company's most recent Annual Report on Form 10-K under the heading "MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS."

SOURCE Labcorp

Share this article

Quva and CAPS collaborate to maintain supply of

critical medications to U.S. hospitals.

SUGAR LAND, Texas and ALLENTOWN, Pa., Sept. 8, 2026 /PRNewswire/ -- QuVa Pharma, Inc. ("Quva") and Central Admixture Pharmacy Services, Inc. ("CAPS") today announced that Quva has acquired a range of essential medications from CAPS following CAPS' decision to exit the 503B sterile compounding business. Quva expects to begin introducing selected products from the acquired portfolio in phases later in 2026 and to expand its offerings over the following six (6) months.

"We are proud to work with Quva, a recognized leader in 503B outsourcing manufacturing, to help ensure continued access to a number of essential medications," said Michael Parden, Chief Executive Officer of B. Braun of America. "Products such as Cardioplegia, Total Parenteral Nutrition and Heparin play an important role in patient care, and this transition supports continuity of supply for the patients and providers who depend on them. We also appreciate Quva's commitment to providing employment opportunities for CAPS colleagues currently supporting our local 503B sterile compounding operations."

Operating from more than 200,000 sq. ft. of FDA-registered 503B manufacturing facilities in New Jersey and Texas and 100,000 sq. ft. of forward distribution centers in Texas and Arizona, Quva serves more than 3,500 hospitals and health system customers nationwide with its broad portfolio of sterile compounded medications manufactured under rigorous quality standards.

"We appreciate the opportunity to partner with CAPS to maintain the supply of these critical medications," said Stuart Hinchen, Chief Executive Officer of Quva. "Health systems depend on prepared medications that are essential to patient care but difficult to produce reliably at scale. This acquisition reflects our commitment to investing in the specialized products, manufacturing capabilities, quality systems, distribution infrastructure, technology, and people needed to support these critical medication categories. We look forward to working with CAPS and our health-system customers to maintain supply and build more dependable solutions for the future."

About Quva

Quva helps health systems address critical medication needs across the enterprise. Through two distinct businesses, Quva supports both the supply of essential prepared medications and the use of complex medication data to improve enterprise decision-making.

Quva Pharma partners with hospitals and health systems to support categories of ready-to-administer and compounded medications that are essential to patient care and difficult to prepare reliably at scale.

Quva BrightStream connects and normalizes medication data from more than 400 source systems across sites of care, helping health-system leaders identify what matters, understand why, and make better decisions.

Together, Quva's businesses share a commitment to helping health systems deliver safe, dependable, and effective medication care.

For more information, visit onequva.com.

About B. Braun

B. Braun Medical Inc. (B. Braun) is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Our purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients—we're uniquely positioned to help health systems succeed now and in the future. B. Braun is headquartered in Bethlehem, Pennsylvania and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®. The company employs 8,500 people at over 30 locations across North America.

Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, explore our website.

SOURCE QuVa Pharma, Inc.

Share this article

KATY, Texas, Sept. 8, 2026 /PRNewswire/ -- Academy Sports + Outdoors (the "Company") (Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, today announced its participation in the upcoming Goldman Sachs 33rd Annual Global Retailing Conference to be held Monday, September 14 to Tuesday, September 15, 2026. Chief Executive Officer, Steve Lawrence, and Chief Financial Officer, Carl Ford, will participate in a fireside chat that will be webcast live on September 15th, at 11:30 a.m. Eastern Time. The live webcast can be accessed through this link: https://cc.webcasts.com/gold006/091426a_js/?entity=30_DHR2B7S

A live and replay webcast (for 30 days) of the fireside chat will be made available on the Company's investor relations website at investors.academy.com.

About Academy Sports + Outdoors

Academy is a leading full-line sporting goods and outdoor recreation retailer in the United States. Originally founded in 1938 as a family business in Texas, Academy has grown to more than 300 stores across 21 states and counting. Academy's mission is to provide "Fun for All" and Academy fulfills this mission with a localized merchandising strategy and value proposition that strongly connects with a broad range of consumers. Academy's product assortment focuses on key categories of outdoor, apparel, sports & recreation and footwear through both leading national brands and a portfolio of private label brands. For more information, visit www.academy.com.

Investor inquiries:

Dan Aldridge, Vice President of Investor Relations

832.739.4102

[email protected]

Media inquiries:

Meredith Klein, Vice President of Communications

346.826.6615

[email protected]

SOURCE Academy Sports + Outdoors

Share this article